Physician profile
Allison Sabo
NPI 1740878008
$4,585.38
in general payments reported to CMS, 2019-2025
24 companies · $97.41 in 2025
The $97.41 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $810 · 2023: $2,120 · 2024: $1,153 · 2025: $97.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,350 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,349.96 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $791.15 | 2021-2024 | Lifevest |
| Pfizer INC. | $516.13 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $348.06 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $347.34 | 2021-2024 | Xarelto |
| Amgen INC. | $335.23 | 2021-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $298.09 | 2021-2024 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $275.21 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $252.23 | 2022-2025 | Amvuttra, Onpattro |
| Heartflow, INC. | $163.73 | 2022-2023 | Ffrct |
| Lexicon Pharmaceuticals, INC. | $163.25 | 2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.91 | 2021-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $133.67 | 2022-2023 | |
| Amarin Pharma, INC. | $128.24 | 2021-2022 | |
| Novo Nordisk INC | $120.83 | 2022 | |
| Scpharmaceuticals INC. | $119.31 | 2023-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $116.68 | 2023-2025 | Nexletol |
| United Therapeutics Corporation | $95.04 | 2021-2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $74.39 | 2024 | |
| Edwards Lifesciences Corporation | $58.25 | 2021-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kiniksa Pharmaceuticals, LTD. | $33.39 | 2023 | Arcalyst |
| Abbott Laboratories | $22.54 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $15.59 | 2023 | |
| Baxter Healthcare | $15.21 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic, INC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Sabo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.